ARTICLE | Clinical News
BVT: Additional Phase IIa data
May 5, 2008 7:00 AM UTC
Biovitrum reported additional data from a Phase IIa trial in 192 diabetic patients with neuropathic pain. Last month, the company said the compound missed the primary endpoint of a significant mean de...